3B Pharmaceuticals GmbH Industries
-
Medical / Health Care
-
-
Peptides and peptidomimetics constitute excellent tumor-specific targeting moieties and can be coupled to therapeutic and diagnostic radioisotopes via a linker and a chelator.
With 3BP’s theragnostic approach, you can see where your drug is going and monitor the efficacy of the treatment. This allows the identification of likely responders leading to faster and cost-efficient clinical trials and increased chances of successful treatment. It also allows personalized dosing based on individual imaging data, thus achieving maximal therapeutic effect with minimal unwanted side effects.